...BRCA1 mutation) were treated with the weak ER activator clomiphene citrate and hormones that are increased during infert...
BRCA1 and BRCA2 mutation carriers have an increased risk for developing breast (and ovarian) cancer. Non-carriers from w...
...BRCA1/2 carriers.,172 patients attended the MDOSC over a 2-year period between 2006 and 2008. A total of 96 and 76 patie...
Mutations in the BRCA1 and BRCA2 genes are responsible for only a part of hereditary breast cancer (HBC). The origins of...
...BRCA1] and von Willebrand factor exon 28 [VWF]). Phylogenetic analyses provided a reference phylogeny and timescale for ...
...BRCA1, SRC, CASP3, and the peroxidases.,The global gene expression profiles provide insight into the cellular mechanisms...
...BRCA1/2 germline mutations by utilizing ALDH-1 immunohistochemistry.,Isolated ALDH-1 positive cells were found in 15/28 ...
...BRCA1 mutation may benefit from tailored treatments, such as with cis-platinum or olaparib. Mutations in BRCA1 are distr...
...BRCA1, GSTP1, EPHB2 and BRCA2 promoter genes.,Prostate cell lines DU-145 and PC-3 were treated with genistein 40 µM, dai...
...BRCA1 and BRCA2 mutations and breast cancer incidence in women with a family history of breast cancer was evaluated. Obs...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
